TD Cowen Upgrades Sana Biotechnology (SANA) to Buy
Tweet Send to a Friend
TD Cowen analyst Marc Frahm upgraded Sana Biotechnology (NASDAQ: SANA) from Hold to Buy.The analyst comments "Sana reported positive IST ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
